Lok Sabha Question No. 892 (UNSTARRED), answered on 2024-11-29
Subject: IMPCL
Ministry: AYUSH
Asked by: Shri Sudhakar Singh

## GOVERNMENT OF INDIA MINISTRY OF AYUSH

## LOK SABHA

## UNSTARRED QUESTION NO. 892 TO BE ANSWERED ON 29.11.2024

## IMPCL

## 892. Shri Sudhakar Singh:

Will the Minister of AYUSH be pleased to state:

- (a) the details of the profitability and financial status of the Indian Medicines Pharmaceutical Corporation Limited (IMPCL);
- (b) the  details  of  the  future  plans  of  the  Government  for  IMPCL  and  the  entire  AYUSH sector;
- (c) whether IMPCL is a profit making organization and if so, the details thereof;
- (d) whether the Government proposes to sell or disinvest in this public sector unit; and
- (e) if so, the details thereof and if not, the reasons therefor?

## ANSWER

## THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYUSH (SHRI PRATAPRAO JADHAV )

- (a) & (c) Indian Medicines Pharmaceutical Corporation Limited (IMPCL) is a profit making organization. The details of the profitability and financial status of IMPCL for Last 5 years are as given below:-

| Financial Year   | Profit before tax (PBT)   | Reserve& Surplus   | Net Worth   |
|------------------|---------------------------|--------------------|-------------|
|                  | Rs. In Lakh               | Rs. In Lakh        | Rs. In Lakh |
| 2019-20          | 42.77                     | 2304.00            | 7502.00     |
| 2020-21          | 1569.04                   | 3396.50            | 8594.50     |
| 2021-22          | 4540.9                    | 6591.23            | 11789.23    |
| 2022-23          | 2948.9                    | 7618.32            | 12816.32    |
| 2023-24          | 1773.34                   | 8258.26            | 13456.26    |

(b)    The Government has no future plan for IMPCL. As regard to Ayush Sector, Ministry of Ayush is already implementing the Centrally Sponsored Scheme of National AYUSH Mission (NAM) through State/UT Governments in the country and supporting their efforts for overall development & promotion of AYUSH systems of medicine by providing financial assistance to them under different activities as per the proposals received in their State Annual Action Plans (SAAPs).  The NAM also includes  various  activities  such  as  Setting  up  of  10/30/50  bedded Integrated Ayush Hospitals, upgradation of existing standalone Government Ayush Hospitals, establishment of new Ayush colleges in the States having inadequate facilities in Government Sector,  upgradation of existing Government/Panchayat/Government aided Ayush Dispensaries, running Ayush Public Health Programmes, etc.

Further Ministry of Ayush is implementing Central Sector Schemes namely AYURGYAN & AYURSWASTHYA since 2021-22.  The aim of Ayurgyan Scheme is to support Research & Innovation in Ayush by providing Extra Mural Research activities, academic activities, training, capacity building etc. The aim of Ayurswasthya Yojana is to promote Ayush intervention for community  health  care  and  to  support  organizations  (Govt./Non-Govt.)  to  upgrade  their functions and facilities.

(d) & (e) The Strategic Disinvestment of Indian Medicines Pharmaceutical Corporation Limited (IMPCL) was approved by the Cabinet Committee of Economic Affairs (CCEA) on 01.11.2017, following the recommendations  of NITI Aayog. The Expression of Interest (EoI) for disinvestment of IMPCL was sought on 31.08.2023 and multiple EoIs have been received by DIPAM, following which the transaction has now moved to the second stage.

*****